Pembrolizumab Exposure-Response Assessments Challenged by Association of Cancer Cachexia and Catabolic Clearance
Turner, David C, Kondic, Anna G, Anderson, Keaven M, Robinson, Andrew G, Garon, Edward B, Riess, Jonathan Wesley, Jain, Lokesh, Mayawala, Kapil, Kang, Jiannan, Ebbinghaus, Scot W, Sinha, Vikram, de Alwis, Dinesh P, Stone, Julie A
Published in Clinical cancer research (01.12.2018)
Published in Clinical cancer research (01.12.2018)
Get full text
Journal Article
Mechanistic Modeling of a Novel Oncolytic Virus, V937, to Describe Viral Kinetic and Dynamic Processes Following Intratumoral and Intravenous Administration
Parra-Guillen, Zinnia P., Freshwater, Tomoko, Cao, Youfang, Mayawala, Kapil, Zalba, Sara, Garrido, Maria J., de Alwis, Dinesh, Troconiz, Iñaki F.
Published in Frontiers in pharmacology (23.07.2021)
Published in Frontiers in pharmacology (23.07.2021)
Get full text
Journal Article
Immunogenicity of pembrolizumab in patients with advanced tumors
van Vugt, Marianne J H, Stone, Julie A, De Greef, Rik H J M M, Snyder, Ellen S, Lipka, Leslie, Turner, David C, Chain, Anne, Lala, Mallika, Li, Mengyao, Robey, Seth H, Kondic, Anna G, De Alwis, Dinesh, Mayawala, Kapil, Jain, Lokesh, Freshwater, Tomoko
Published in Journal for immunotherapy of cancer (08.08.2019)
Published in Journal for immunotherapy of cancer (08.08.2019)
Get full text
Journal Article
First‐in‐human phase 1 study of MK‐1248, an anti–glucocorticoid‐induced tumor necrosis factor receptor agonist monoclonal antibody, as monotherapy or with pembrolizumab in patients with advanced solid tumors
Geva, Ravit, Voskoboynik, Mark, Dobrenkov, Konstantin, Mayawala, Kapil, Gwo, Jennifer, Wnek, Richard, Chartash, Elliot, Long, Georgina V.
Published in Cancer (15.11.2020)
Published in Cancer (15.11.2020)
Get full text
Journal Article
A six-weekly dosing schedule for pembrolizumab in patients with cancer based on evaluation using modelling and simulation
Lala, Mallika, Li, Tommy Ruosi, de Alwis, Dinesh P., Sinha, Vikram, Mayawala, Kapil, Yamamoto, Noboru, Siu, Lillian L., Chartash, Elliot, Aboshady, Hesham, Jain, Lokesh
Published in European journal of cancer (1990) (01.05.2020)
Published in European journal of cancer (1990) (01.05.2020)
Get full text
Journal Article
Mechanistic Basis for Maximally Efficacious Dose of Pembrolizumab
Mayawala, Kapil, Nayak, Tapan, Jain, Lokesh, de Alwis, Dinesh
Published in Clinical pharmacology and therapeutics (01.05.2022)
Published in Clinical pharmacology and therapeutics (01.05.2022)
Get more information
Journal Article
Abstract PO-131: Inter-tumoral heterogeneity of progressive disease in melanoma patients treated with pembrolizumab
Topp, Brian, Kumar, Rukmini, Mayawala, Kapil, de Alwis, Dinesh, Hellmann, Matt D., Snyder, Alexandra
Published in Cancer research (Chicago, Ill.) (01.11.2020)
Published in Cancer research (Chicago, Ill.) (01.11.2020)
Get full text
Journal Article
Tumor dynamics in patients with solid tumors treated with pembrolizumab beyond disease progression
Topp, Brian G., Channavazzala, Madhav, Mayawala, Kapil, De Alwis, Dinesh P., Rubin, Eric, Snyder, Alexandra, Wolchok, Jedd D., Ribas, Antoni
Published in Cancer cell (11.09.2023)
Published in Cancer cell (11.09.2023)
Get full text
Journal Article
Model Informed Drug Development: Novel Oncology Agents are Lost in Translation
Mayawala, Kapil, de Alwis, Dinesh P, Sachs, Jeffrey R
Published in Clinical cancer research (15.11.2019)
Published in Clinical cancer research (15.11.2019)
Get full text
Journal Article
Pivotal Dose of Pembrolizumab: A Dose-Finding Strategy for Immuno-Oncology
Li, Tommy R, Chatterjee, Manash, Lala, Mallika, Abraham, Anson K, Freshwater, Tomoko, Jain, Lokesh, Sinha, Vikram, de Alwis, Dinesh P, Mayawala, Kapil
Published in Clinical pharmacology and therapeutics (01.07.2021)
Published in Clinical pharmacology and therapeutics (01.07.2021)
Get more information
Journal Article
Assessment of Clinical Response to V937 Oncolytic Virus After Intravenous or Intratumoral Administration Using Physiologically-Based Modeling
Parra-Guillen, Zinnia P, Sancho-Araiz, Aymara, Mayawala, Kapil, Zalba, Sara, Garrido, Maria J, de Alwis, Dinesh, Troconiz, Iñaki F, Freshwater, Tomoko
Published in Clinical pharmacology and therapeutics (01.09.2023)
Published in Clinical pharmacology and therapeutics (01.09.2023)
Get more information
Journal Article
Strategies and Recommendations for Using a Data-Driven and Risk-Based Approach in the Selection of First-in-Human Starting Dose: An International Consortium for Innovation and Quality in Pharmaceutical Development (IQ) Assessment
Leach, Michael W, Clarke, David O, Dudal, Sherri, Han, Chao, Li, Chunze, Yang, Zheng, Brennan, Frank R, Bailey, Wendy J, Chen, Yingxue, Deslandes, Antoine, Loberg, Lise I, Mayawala, Kapil, Rogge, Mark C, Todd, Marque, Chemuturi, Nagendra V
Published in Clinical pharmacology and therapeutics (01.06.2021)
Published in Clinical pharmacology and therapeutics (01.06.2021)
Get more information
Journal Article
Corrigendum to “A six-weekly (Q6W) dosing schedule for pembrolizumab in patients with cancer based on evaluation using modelling and simulation” [Eur J Canc 131 (2020) 68–75]
Lala, Mallika, Li, Tommy Ruosi, de Alwis, Dinesh P., Sinha, Vikram, Mayawala, Kapil, Li, Mengyao, Yamamoto, Noboru, Siu, Lillian L., Chartash, Elliot, Aboshady, Hesham, Jain, Lokesh
Published in European journal of cancer (1990) (01.02.2021)
Published in European journal of cancer (1990) (01.02.2021)
Get full text
Journal Article
Experimental Medicine Study to Measure Immune Checkpoint Receptors PD‐1 and GITR Turnover Rates In Vivo in Humans
Lassman, Michael E., Chappell, Derek L., McAvoy, Thomas, Cheng, Amy, Alwis, Dinesh P., Pruitt, Scott K., Laterza, Omar F., Li, Claire, Stoch, Aubrey, Mayawala, Kapil
Published in Clinical pharmacology and therapeutics (01.06.2021)
Published in Clinical pharmacology and therapeutics (01.06.2021)
Get full text
Journal Article